Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 144Neoplasms 130Prostatic Neoplasms 81Carcinoma, Non-Small-Cell Lung 79Lung Neoplasms 65Colorectal Neoplasms 46Carcinoma, Hepatocellular 37Stomach Neoplasms 33Multiple Myeloma 28Brain Neoplasms 28Uterine Cervical Neoplasms 27Melanoma 26Pancreatic Neoplasms 25Rectal Neoplasms 24Ovarian Neoplasms 24Head and Neck Neoplasms 23Colonic Neoplasms 23Urinary Bladder Neoplasms 22Hematologic Neoplasms 22Neoplasm Metastasis 21Esophageal Neoplasms 20Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Endometrial Neoplasms 17Recurrence 15Cardiovascular Diseases 15Thyroid Neoplasms 14Lymphoma 14Liver Neoplasms 14

Interventions

Sentinel Lymph Node Biopsy 1Ovariectomy 1Hysterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Observational × FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma × Clear all
NCT04604613 2026-03-09

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

M.D. Anderson Cancer Center

Active not recruiting
518 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡